Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

209 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

BELGIUM

LIEGE
LIEGE

GERMANY

Baden-Württemberg
FREIBURG

Recruiting trial
Ongoing trial
CA209-9P9: Phase 1/2 Study on the Efficacy of Nivolumab in the Recurrence of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Universitätsklinikum Freiburg
Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
BLAST: A double- blind, placebo controlled, randomized, multicenter, Phase II study to assess the efficacy of BL-8040 addition to consolidation therapy in AML patients - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Hessen
FRANKFURT AM MAIN

GERMANY

Nordrhein-Westfalen
ESSEN

Recruiting trial
Ongoing trial
AML-BFM 2012: Clinical trial for the treatment of acute myeloid leukemia in children and adolescents
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

GERMANY

Sachsen
DRESDEN

GERMANY

Sachsen
DRESDEN

Recruiting trial
Ongoing trial
TUD-BRIDGE-046: Clofarabine salvage therapy in patients with relapsed or refractory Acute Myeloid Leukemia (Phase II Study)
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Medizinische Klinik und Poliklinik I - Fachbereich Hämatologie und Blutstammzelltransplantation

GERMANY

Sachsen
DRESDEN

Recruiting trial
Ongoing trial
ETAL3-ASAP: Evaluation of the Impact of Remission Induction Chemotherapy Prior to Allogeneic Stem Cell Transplantation in Relapsed and Poor-response Patients with AML (Phase III) - DE
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Medizinische Klinik und Poliklinik I - Fachbereich Hämatologie und Blutstammzelltransplantation

GERMANY

Sachsen
LEIPZIG

NETHERLANDS

Zuid-Holland
LEIDEN

SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

SPAIN

Comunidad Valenciana
VALENCIA

SWITZERLAND

Suisse Romande
LAUSANNE

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Nottinghamshire
NOTTINGHAM

UNITED KINGDOM

South Glamorgan
CARDIFF

FRANCE

ILE-DE-FRANCE
LE CHESNAY

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A phase II study of the efficacy and safety of lenalidomide combined to azacitidine in intermediate-2 or high risk MDS AND AML with del 5q (GFM-Aza-Rev-09)
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Groupe Francophone des Myélodysplasies (GFM)

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Baden-Württemberg
FREIBURG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
CD3/CD19 Haplo (E410/2007): Multicenter phase II study of Haploidentical Hematopoietic Cell Transplantation with CD3/CD19 depleted Grafts after a reduced intensity conditioning regimen for adult Patients with Acute Leukemia
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

GERMANY

Bayern
MÜNCHEN

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Hessen
FRANKFURT AM MAIN

Recruiting trial
Ongoing trial
PANOBEST: Phase I/II study with oral panobinostat maintenance therapy following allogeneic stem cell transplantation in patients with high risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Medizinische Klinik II - Hämatologie, Onkologie, Hämostaseologie, Rheumatologie, Infektiologie

GERMANY

Sachsen
LEIPZIG

Recruiting trial
Ongoing trial
BERGAMO: A Phase II Study Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes Failing Standard of Care Therapy -DE
Universitätsklinikum Leipzig AöR
Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie

ITALY

FRIULI VENEZIA GIULIA
UDINE

ITALY

LAZIO
ROMA

Recruiting trial
Ongoing trial
Study protocol for acute myeloid leukemia in children and adolescent
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Onco-Ematologia

ITALY

LAZIO
ROMA

UNITED KINGDOM

South Glamorgan
CARDIFF

Ongoing trial
AML 16: A Programme of Treatment Development for Older Patients With Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome (PhaseII/III)
Cardiff University School of Medicine
Department of Medical Genetics, Haematology & Pathology

UNITED KINGDOM

South Glamorgan
CARDIFF

Recruiting trial
Ongoing trial
AML 17: Randomised, controlled, open label, multi-arm trial looking at treatment for acute promyelocytic leukaemia (Phase III)
Cardiff University School of Medicine
Department of Medical Genetics, Haematology & Pathology

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

GERMANY

Hamburg
HAMBURG

GERMANY

Sachsen
LEIPZIG

BERGAMO: A Phase II Study Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes Failing Standard of Care Therapy
Universitätsklinikum Leipzig AöR
Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie

UNITED STATES

New Jersey
RARITAN